Clinical Trial Update: To Assess the Efficacy and Safety of RVT-1401 in the Treatment of Warm Autoimmune Hemolytic Anemia (ASCEND-WAIHA). [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy and safety of RVT-1401 in warm autoimmune hemolytic anemia was terminated; results were posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Warm Autoimmune Hemolytic Anemia

Drugs mentioned

• RVT-1401

Snippet

Sponsor: Immunovant Sciences GmbH | Conditions: Warm Autoimmune Hemolytic Anemia | Phase 2 | Status: TERMINATED | Results posted: 2022-07-28